
Rathi joins Citi from Dream Sports, where he served as head of strategy and corporate development.
Sun Pharma’s acquisition of Organon marks a pivot toward biosimilars, utilizing a cheap valuation and strong cash reserves to avoid the chronic post-merger stock slumps seen by Indian rivals.